Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$40.24 USD
-0.68 (-1.66%)
Updated Oct 14, 2025 04:00 PM ET
After-Market: $40.22 -0.02 (-0.05%) 6:42 PM ET
5-Strong Sell of 5 5
D Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Agios Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AGIO 40.24 -0.68(-1.66%)
Will AGIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AGIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGIO
AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia
Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?
AGIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
Ultragenyx (RARE) Up 9.6% Since Last Earnings Report: Can It Continue?
Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?
Other News for AGIO
AGIO's price rises by 0.76% on October 13, though its technical setup remains stable.
AGIO forms Slingshot Bullish on October 10
AGIO forms Upper Bollinger Band Walk on October 9
COMMODORE CAPITAL LP Acquires Significant Stake in SAB Biotherapeutics Inc
AGIO rises 4.23% on October 8, leaving the technical picture intact